Biotechnology company develops potential biofilm-busting treatment for infections

A researcher presented biotechnology at the Medtech Showcase in San Francisco Jan. 12 that can be used to destroy biofilms and potentially treat bacterial infections.

The researcher is Steven Goodman, PhD, associate professor of pediatrics at the Ohio State College of Medicine, principal investigator at the Research Institute of Nationwide Children's Hospital in Columbus and a member of the scientific board for Ohio-based biotechnology company ProclaRx.

According to Dr. Goodman, ProclaRx's new technology can break down the physical barriers that protect bacteria and prevent antibiotics from attacking chronic infections.

ProclaRx CEO Joseph D. Kittle Jr., PhD, noted the technology is "unusual in that it can support both therapeutic as well as medical device products."



More articles on bacterial infections:
Researchers reveal 'tentacles' UTI bacteria use to stay put during infection
Princeton researchers show how bacteria communicate, create infections
Deadly bacteria flew under many scientists' radar, until now: 5 things to know

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars